Pfizer said shareholders elected the board nominees at its April 24, 2025 Annual Meeting of Shareholders, and that the elected directors will hold office until the next Annual Meeting. For example, Albert Bourla received 3,246,800,234 votes for and 307,245,700 votes against.

1. 01

   Pfizer said shareholders elected the board nominees at its April 24, 2025 Annual Meeting of Shareholders, and that the elected directors will hold office until the next Annual Meeting. For example, Albert Bourla received 3,246,800,234 votes for and 307,245,700 votes against.

2. 02

   The company said shareholders approved the selection of KPMG LLP as its independent registered public accounting firm for fiscal 2025. The votes were 4,216,654,548 for, 300,423,270 against and 18,745,406 abstentions, and broker non-votes were not applicable (n/a).

3. 03

   The company said shareholders approved, on an advisory basis, the fiscal 2025 compensation of its Named Executive Officers. The proposal received 1,947,064,397 votes for, 1,612,203,678 votes against, 21,901,539 abstentions and 954,654,621 broker non-votes.

4. 04

   The company said a shareholder proposal to adopt a shareholder vote on golden parachutes was not approved, with 338,488,044 votes for and 3,208,877,595 votes against. A shareholder proposal to issue a report evaluating the risks related to religious discrimination against employees was also not approved, with 71,070,282 votes for and 3,448,108,236 votes against.

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.